January 28, 2025
TOPLINE: Elevated concentrations of serum polychlorinated biphenyls (PCBs) increase the risk for incident cardiovascular disease (CVD) by up to 30% among patients with type 2 diabetes […]
January 27, 2025
Weight loss is crucial for improving health and decreasing disease risk in those with overweight and obesity. Unfortunately, many individuals who lose weight through lifestyle interventions […]
January 27, 2025
(Reuters) -Veru said on Monday its experimental drug in combination with Novo Nordisk’s weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the […]
January 27, 2025
New research, with the caveat of a relatively short follow-up, adds to encouraging data showing an overall low risk of the development of thyroid cancer associated […]
January 24, 2025
TOPLINE: Higher intake of lignans — a group of plant-based antioxidants abundant in flaxseeds, whole grains, coffee, and some fruits and vegetables — is associated with […]
January 24, 2025
The arrival of drugs that mimic the gut hormone glucagon-like peptide 1 (GLP-1) has revolutionized the treatment of overweight and obesity, offering a biologic intervention that […]
January 24, 2025
(Reuters) – One of Novo Nordisk’s next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their weight in 36 […]
January 24, 2025
TOPLINE: Combining dapagliflozin with calorie restriction achieved a greater type 2 diabetes (T2D) remission rate and significant changes in body fat and metabolic risk factors than […]
January 23, 2025
TOPLINE: Fasting plasma glucose levels outside 80-94 mg/dL, male sex, older age, and abnormal body mass index (BMI) categories all contribute to diabetes development, with additive […]